Favourable factors for IA course in children are haematological recovery and remission of malignancy. Current IA diagnostics is based on: conventional microbiological methods, serological assays (galactomannan, 1,3-beta-D-glucan), molecular tests and radiology (mainly HRCT). Mortality in children with Cl-amidine IA after allo-HSCT over the last decade was
up to 75-90%. Currently, results of IA therapy are improving. This review presents updated definition and classifications of IA, as well as pharmacological strategies of antifungal prophylaxis and therapy. The characteristics and experience in use of antifungal drugs in IA in children are presented.”
“There is accumulating evidence that adipokines lead to a proinflammatory state, which plays crucial roles in insulin resistance and development of type 2 diabetes mellitus (T2DM). Previous studies demonstrated that weight loss after bariatric surgery is accompanied by a suppression of the proinflammatory state. However, the effect of bariatric surgery on adipokine expression beyond weight loss is still elusive. The aim of this study was to investigate
the effect of duodenal-jejunal bypass (DJB) on glucose homeostasis and adipokine expression independently of weight loss.\n\nA T2DM rat model was developed by a high-fat diet and low dose of streptozotocin. Twenty-one diabetic rats GDC0068 and 10 age-matched SD rats were randomly assigned to the DJB group, sham-DJB (S-DJB) group, and control
group. For 12 weeks after surgery, their body weight, food intake, glucose homeostasis, lipid parameters, serum adipokine levels, and adipokine gene expression in the mesocolon adipose tissue were measured.\n\nCompared to the S-DJB group, DJB induced significant and sustained glycemic control with improved insulin sensitivity and glucose tolerance independently of weight loss. DJB improved the lipid metabolism by decreasing fasting free fatty acids and triglycerides. Serum leptin and IL-6 significantly decreased 12 weeks after DJB, whereas adiponectin increased and TNF-alpha remained unchanged. VS-4718 The mRNA expression levels of leptin, TNF-alpha, and IL-6 decreased, whereas adiponectin increased in the mesocolon adipose tissue.\n\nDJB reduced the proinflammatory adipokines and increased the anti-inflammatory adipokines independently of weight loss, which may contribute to the improvement of insulin sensitivity.”
“Interindividual heterogeneity in drug response is a central feature of all drug therapies. Studies in individual patients, families, and populations over the past several decades have identified variants in genes encoding drug elimination or drug target pathways that in some cases contribute substantially to variable efficacy and toxicity.